Showing 1 - 2 results of 2 for search 'Isabelle Bence‐Bruckler', query time: 0.02s Refine Results
  1. 1
    Characteristics of relapsed/refractory diffuse large B‐cell lymphoma patients with durable responses to maveropepimut‐S, pembrolizumab, and cyclophosphamide: Long‐term follow‐up from the SPiReL trial

    Characteristics of relapsed/refractory diffuse large B‐cell lymphoma patients with durable responses to maveropepimut‐S, pembrolizumab, and cyclophosphamide: Long‐term follow‐up fr... by Arjun Pandey, Kim Roos, Yidi Jiang, Kathryn Mangoff, Gail Klein, Nick Forward, Douglas Stewart, Pierre Laneuville, Isabelle Bence‐Bruckler, Joy Mangel, George Tomlinson, Neil L. Berinstein

    Published 2025-02-01
    Get full text
    Article
  2. 2
    356 Baseline PD-L1 expression and tumor immune infiltration is associated with clinical response in patients with r/r DLBCL treated with DPX-Survivac, low-dose cyclophosphamide and pembrolizumab

    356 Baseline PD-L1 expression and tumor immune infiltration is associated with clinical response in patients with r/r DLBCL treated with DPX-Survivac, low-dose cyclophosphamide and... by Neil Berinstein, Isabelle Bence-Bruckler, Nick Forward, Pierre Laneuville, Joy Mangel, Douglas Stewart, Irina Amitai, Gail Klein, Nancy Pennell, Iran Rashedi, Kim Roos, Yogesh Bramhecha, Rebekah Conlon

    Published 2020-11-01
    Article

Search Tools: